Skip to main content

Table 4 Outcome measures at pre-operation, 6 weeks, 12 weeks, 6 months, and 12 months

From: The clinical efficacy of arthroscopic therapy with knee infrapatellar fat pad cell concentrates in treating knee cartilage lesion: a prospective, randomized, and controlled study

Parameter Experiment group Control group P values
WOMAC pain Pre-op 4.83 ± 2.94 4.96 ± 3.16 > 0.05
  6 weeks 4.57 ± 3.80 5.6 ± 4.24 > 0.05
  12 weeks 3.10 ± 2.95 3.60 ± 3.12 > 0.05
  6 months 1.77 ± 2.06 2.83 ± 2.09 > 0.05
  12 months 1.00 ± 1.26 2.73 ± 2.23 < 0.05
WOMAC stiffness Pre-op 1.07 ± 1.11 1.33 ± 1.49 > 0.05
  6 weeks 1.80 ± 1.40 1.9 ± 2.02 > 0.05
  12 weeks 1.17 ± 1.32 1.2 ± 1.19 > 0.05
  6 months 0.87 ± 1.14 0.93 ± 1.05 > 0.05
  12 months 0.63 ± 1.10 0.86 ± 0.94 > 0.05
WOMAC function Pre-op 13.30 ± 9.26 13.73 ± 11.97 > 0.05
  6 weeks 15.93 ± 13.81 14.83 ± 11.00 > 0.05
  12 weeks 11.60 ± 12.11 12.7 ± 10.19 > 0.05
  6 months 6.70 ± 6.96 10.27 ± 8.53 < 0.05
  12 months 4.30 ± 4.04 10.13 ± 8.82 < 0.05
WOMAC total Pre-op 19.20 ± 11.90 19.90 ± 14.19 > 0.05
  6 weeks 22.30 ± 17.67 22.23 ± 13.14 > 0.05
  12 weeks 15.87 ± 15.13 17.43 ± 12.05 > 0.05
  6 months 9.33 ± 9.44 14.03 ± 9.58 < 0.05
  12 months 5.93 ± 5.84 13.73 ± 9.85 < 0.05
VAS rest Pre-op 1.40 ± 1.48 1.50 ± 1.41 > 0.05
  6 weeks 1.47 ± 1.61 1.93 ± 1.57 > 0.05
  12 weeks 0.53 ± 1.01 0.97 ± 1.00 > 0.05
  6 months 0.30 ± 0.60 0.77 ± 0.94 > 0.05
  12 months 0.10 ± 0.30 0.73 ± 0.90 < 0.05
VAS motion Pre-op 4.50 ± 1.76 4.43 ± 2.13 > 0.05
  6 weeks 3.70 ± 1.58 3.8 ± 1.06 > 0.05
  12 weeks 2.60 ± 1.99 2.83 ± 1.05 > 0.05
  6 months 1.67 ± 1.90 2.53 ± 1.25 > 0.05
  12 months 0.77 ± 0.90 2.3 ± 1.21 < 0.05
MOCART Pre-op 48.33 ± 5.22 48.17 ± 5.68 > 0.05
  12 months 73.45 ± 6.28 52.68 ± 7.26 < 0.05
  1. Data are presented as mean ± SD